Handelsbanken Fonder
INDV icon

Handelsbanken Fonder’s Indivior Pharmaceuticals INDV Stock Holding History

Handelsbanken Fonder’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
45,300
-5,100
-10% -$185K 0.01% 839
2026
Q1 		$1.54M Buy
+50,400
New +$1.66M 0.01% 849

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Oaktree Capital Management
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Handelsbanken Fonder's INDV Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Indivior Pharmaceuticals (INDV) stake by 10% in Q2 2026, selling an estimated $185K and leaving 45,300 shares worth $1.86M. The position accounts for 0.01% of the portfolio, ranked #839.

Handelsbanken Fonder first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Handelsbanken Fonder held 45,300 shares of Indivior Pharmaceuticals worth $1.86M as of Q2 2026.
  • Handelsbanken Fonder sold 5,100 Indivior Pharmaceuticals shares in Q2 2026, an estimated $185K.
  • Indivior Pharmaceuticals made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #839 holding.
  • Handelsbanken Fonder first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.